Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Bon

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Oncogene|September 20, 2005
Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesionShantaram Bharadwaj, Ruchi Thanawala, Giulia Bon, et al.
Breast Cancer Research : BCR|February 27, 2007
Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progressionGiulia Bon, Valentina Folgiero, Selene Di Carlo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivationGiulia Bon, Valentina Folgiero, Gianluca Bossi, et al.
Cancer Research|February 20, 2007
The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and functionValentina Folgiero, Robin E Bachelder, Giulia Bon, et al.
Frontiers in Oncology|July 11, 2022
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging IssueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Frontiers in Oncology|November 17, 2022
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Journal of Translational Medicine|May 3, 2024
Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancerGiulia Schiavoni, Beatrice Messina, Stefano Scalera, et al.
Journal of Translational Medicine|February 29, 2024
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancerGiulia Schiavoni, Beatrice Messina, Stefano Scalera, et al.
Cell Transplantation|January 7, 2011
Purification and characterization of adipose-derived stem cells from patients with lipoaspirate transplantValentina Folgiero, Emilia Migliano, Marinella Tedesco, et al.
Cell Death & Disease|January 12, 2023
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progressionBeatrice Messina, Federica Lo Sardo, Stefano Scalera, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Oncogene|September 20, 2005
Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesionShantaram Bharadwaj, Ruchi Thanawala, Giulia Bon, et al.
Breast Cancer Research : BCR|February 27, 2007
Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progressionGiulia Bon, Valentina Folgiero, Selene Di Carlo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivationGiulia Bon, Valentina Folgiero, Gianluca Bossi, et al.
Cancer Research|February 20, 2007
The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and functionValentina Folgiero, Robin E Bachelder, Giulia Bon, et al.
Frontiers in Oncology|July 11, 2022
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging IssueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Frontiers in Oncology|November 17, 2022
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issueRossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, et al.
Journal of Translational Medicine|May 3, 2024
Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancerGiulia Schiavoni, Beatrice Messina, Stefano Scalera, et al.
Journal of Translational Medicine|February 29, 2024
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancerGiulia Schiavoni, Beatrice Messina, Stefano Scalera, et al.
Cell Transplantation|January 7, 2011
Purification and characterization of adipose-derived stem cells from patients with lipoaspirate transplantValentina Folgiero, Emilia Migliano, Marinella Tedesco, et al.
Cell Death & Disease|January 12, 2023
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progressionBeatrice Messina, Federica Lo Sardo, Stefano Scalera, et al.
Pageof 3